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Lower respiratory tract infections (LRTIs) are the fifth leading cause of illness globally.1 Despite causing an 
estimated 2.6 million deaths in 2017 and 
being ranked the fourth most common 
cause of death globally, LRTIs do not affect 
populations uniformly.2 The burden of 
LRTI has been heterogeneous with respect 
to socioeconomic and environmental 
characteristics with disadvantaged 
populations experiencing higher loss of 
life-years.3 LRTIs are responsible for a large 
proportion of the morbidity and mortality 
faced by Indigenous people globally.4 In 
Australia, the prevalence of respiratory 
diseases is reported to be higher for all age 
groups of Aboriginal and Torres Strait Islander 
people than for non-Indigenous people.5 
This is despite the ‘Closing the Gap’ strategy 
that aims to reduce the disadvantage of 
Aboriginal and Torres Strait Islander people 
(respectfully referred to as Indigenous from 
herein) with respect to health, education and 
employment outcomes. The health disparities 
between Indigenous and non-Indigenous 
children are even more pronounced, with 
Indigenous children experiencing up to six 
times higher LRTI-related hospitalisations 
and having a higher prevalence of co-
morbidities.6-8 
The analysis of health inequalities for LRTIs 
between Indigenous and non-Indigenous 
communities has largely focused on 
children. This has been partly warranted 
as the large proportion of lung diseases 
and complications in adults stem from 
childhood, when these respiratory conditions 
are treatable and preventable.9 However, 
Indigenous and non-Indigenous adults also 
experience significant disparity in rates of 
respiratory illnesses, which disproportionately 
affects health outcomes and quality of life. 
In this study, we extended the literature 
and investigated the epidemiology of LRTI 
and associated hospital admissions and 
health outcomes for Indigenous and non-
Indigenous populations using a tertiary 
hospital admissions database for the 11-year 
period between 2006 and 2016. We also 
described the dynamics of LRTI-related 
diseases for hospital admissions across 
time and identified the patterns in hospital 
admissions during the disease outbreaks. As 
we are now amid the COVID-19 pandemic 
(as of December 2020), this empirical analysis 
is potentially useful in highlighting the 
importance of preventative strategies and 
the promotion of protective measures among 
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Abstract
Objective: To investigate the admission characteristics and hospital outcomes for patients 
admitted with lower respiratory tract infections (LRTI) in Northern Queensland.
Methods: We perform a retrospective analysis of the data covering an 11-year period, 
2006–2016. Length of hospital stay (LOS) is modelled by negative binomial regression and 
heterogeneous effects are checked using interaction terms. 
Results: A total of 11,726 patients were admitted due to LRTI; 2,430 (20.9%) were of Indigenous 
descent. We found higher hospitalisations due to LRTI for Indigenous than non-Indigenous 
patients, with a disproportionate increase in hospitalisations occurring during winter. The LOS 
for Indigenous patients was higher by 2.5 days [95%CI: -0.15; 5.05] than for non-Indigenous 
patients. The average marginal effect of 17.5 [95%CI: 15.3; 29.7] implies that the LOS for a 
patient, who was admitted to ICU, was higher by 17.5 days.
Conclusions: We highlighted the increased burden of LRTIs experienced by Indigenous 
populations, with this information potentially being useful for enhancing community-level 
policy making.
Implications for public health: Future guidelines can use these results to make 
recommendations for preventative measures in Indigenous communities. Improvements in 
engagement and partnership with Indigenous communities and consumers can help increase 
healthcare uptake and reduce the burden of respiratory diseases.
Key words: lower respiratory tract infections, Indigenous health, socioeconomic disadvantage, 
health policy
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level care for 670,000 people. A cohort of 
inpatients for this study was identified based 
on ICD-10-AM discharge codes for influenza 
(J09-J11), pneumonia (J12-J18), bronchitis 
(J20, J21), and other LRTI (J22). Our data 
are a subset of the large relational dataset 
that contains information on all inpatients 
with infectious disease diagnoses. Details of 
the data and linking procedures have been 
described in detail elsewhere.10 
To control for socioeconomic and 
environmental measures that may explain 
the variation in the health outcomes between 
Indigenous and non-Indigenous populations, 
we used the Index of Relative Socio-Economic 
Disadvantage (IRSD) from Socio-Economic 
Indexes for Areas (SEIFA), which summarises 
information about the economic and social 
conditions of people and households within 
geographical areas. Using the residential 
postcode information of patients and the 
year of admission, we supplemented our 
dataset with the IRSD values that are based 
on information from the five-yearly Census 
(2006, 2011, 2016). The year of admission was 
matched with the closest census year. 
Statistical analysis
We presented the results as frequencies 
and percentages for categorical variables 
and means with standard deviation (SD) for 
continuous variables of patient characteristics 
and admissions measurements. T-test and 
chi-square tests were used for comparisons 
between Indigenous and non-Indigenous 
groups after checking the distributions of the 
measurements.
We also explored the length of hospital stay 
(LOS) by using a negative binomial model and 
checked heterogeneity between Indigenous 
and non-Indigenous groups. We selected a 
negative binomial regression over a Poisson 
model to study LOS in days due to the 
presence of overdispersion in the data, which 
is confirmed by the chi-square test (p-value 
<0.001). Because the model is non-linear, we 
used marginal effects to interpret the impact 
on the predicted counts due to the changes 
in the explanatory variables. A z-test of the 
second difference was used to test interaction 
effects between Indigenous status and 
diagnosis groups. 
As the number of cases and severity of 
acute LRTI episodes potentially depend on 
seasonality, we adjusted for month and year 
fixed effects in all models. Standard errors 
were clustered by patients to account for 
autocorrelation within individuals who had 
multiple admissions during the observation 
period. The results are presented in log-ratios 
and marginal effects. The data were analysed 
using R software environment (RStudio 
1.2.5033) and Stata (version 15.1).
Ethical approval
This research is part of the project (HREC/16/
QTHS/221), which was approved by the 
Townsville Hospital and Health Service (THHS) 
Human Research Ethics Committee. A waiver 
of consent for access to anonymised historical 
data was approved under the Queensland 
Public Health Act (RD007802). We note that 
patients or members of the public were not 
involved in the design or implementation of 
this research and that anonymised historical 
data extraction did not require any patient 
recruitment.
Results
Descriptive statistics for hospital 
admissions 
Table 1 presents the characteristics of the 
patients included in this study. During 
the study period, 11,643 patients were 
admitted to the Townsville hospital with 
LRTI-related diagnosis. Of these patients, 
14 patients were excluded as they did not 
have information on their Indigenous status. 
About 20.8% (2430/11,629) of patients 
were of Indigenous descent with slightly 
more males than females admitted to the 
hospital. The proportion of the patients in 
our sample identified as Indigenous is higher 
than in the population of the Townsville 
region (during 2006–2016, the percentage 
of Indigenous peoples varied from 7.1% 
to 7.8%).10,11 Indigenous patients were 
significantly younger than non-Indigenous, 
with an average age difference of more than 
20 years (38.7 years vs. 59.4 years). This also 
corresponds to the census data that report 
a 16-year difference in the median age 
between Indigenous and non-Indigenous 
Queensland populations.12 
Our data also show that the majority of 
patients from both groups had pneumonia-
related diagnoses and the proportions of 
influenza and other LRTI diagnoses among 
Indigenous and non-Indigenous groups were 
similar. On the other hand, the proportion 
of bronchitis cases for Indigenous patients 
(10.5%) were more than twice than for non-
Indigenous (5.1%). This was largely driven by 
the higher proportion of Indigenous infants 
and toddlers (17.7% vs. 8.6%) who were 
admitted to the hospital. The average LOS 
and time in ICU for Indigenous (11.4 days 
and 192.9 hours) and non-Indigenous (10.7 
days and 171.5 hours) are not significantly 
different. We found evidence that Indigenous 
patients lived in more disadvantaged areas 
measured by the IRSD score (957.7 vs. 990.6). 
The hospital Emergency Department was the 
main pathway to hospital admission for both 
Indigenous and non-Indigenous patients, 
67.7% and 72.0%, respectively. A higher 
proportion of Indigenous patients were 
transferred from other hospitals (17.3% vs. 
7.4%). More patients who are non-Indigenous 
received admission through other channels 
such as residential aged care services. The 
age profile is also associated with mortality. 
More than 82% (883) of all deaths in our 
sample involved patients aged 60 years 
or older. We also found significant differences 
in the care type, with more non-Indigenous 
patients using palliative care (2.0% vs. 0.6%) 
and rehabilitation care (1.5% vs. 0.6%) than 
Indigenous patients.
Dynamics of hospital admissions
Figure 1 reflects the seasonal nature of LRTI 
and significant variation in the number 
of hospital visits depending on disease 
characteristics, particularly during the 
influenza season. There is an increasing 
general trend in the use of health services 
associated with LRTIs with progressively more 
admissions and winter surges throughout the 
study. 
Figure 2 describes the monthly dynamics 
for pneumonia, influenza, bronchitis and 
other LRTIs by Indigenous status. The counts 
of hospital admissions are transformed to 
the admission rates per 10,000 residents of 
respective population groups using yearly 
Townsville resident population statistics. For 
all diagnosis groups and almost all monthly 
time periods, the rates were significantly 
higher for the Indigenous population. Thus, 
the admission rates for pneumonia and 
influenza for Indigenous patients were up to 
seven times higher than for non-Indigenous 
patients. Figure 2 (B) also highlights that, 
particularly during significant influenza 
outbreaks, the Indigenous population is 
highly exposed to the infection and many 
people are likely to be admitted to the 
hospital for treatment. 
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Determinants of length of stay (LOS) 
of LRTI-related hospitalisations
Furthermore, we examined whether there 
were significant differences in LOS between 
Indigenous and non-Indigenous patients 
after controlling for available confounders. 
We used the ICU attendance to account 
for severity and type of care provided to 
differentiate between acute and palliative 
treatments. 
The results from Model I in Table 2 showed 
that Indigenous status associated with LOS for 
Indigenous patients was higher by 2.4 days 
(95%CI: -0.2, 5.1) than for non-Indigenous 
patients. This represented a relatively large 
increase compared to the mean LOS value 
of 10.9 days in the full sample. ICU treatment 
was also a significant covariate and positively 
related to LOS. The average marginal effect of 
17.5 (95%CI: 15.3, 19.7) implies that the LOS 
for a patient who was admitted to ICU was 
higher on average by 17.5 days. Furthermore, 
females and younger patients are predicted 
to spend significantly less time in the hospital 
for LRTI-related hospitalisation than males 
and older people, respectively, which may be 
associated with underlying health conditions 
and co-morbidities.
The LOS was not uniformly associated among 
diagnosis groups. For example, if a patient 
was admitted to hospital for pneumonia in 
comparison to influenza, the LOS was longer 
by 3.6 days (95%CI: 2.3, 4.8). Even more 
interesting findings relate to the relatively 
high burden of other LRTIs. Here, the higher 
average marginal effects in comparison to 
influenza indicate that the LOS on average 
was higher for the other LRTI by 3.1 days 
(95%CI: 1.2, 4.9).
We were interested in whether the 
Indigenous status gap was bigger or smaller 
for patients with different LRTI diagnosis. 
To test this potential heterogeneity, we 
included an interaction term between 
Indigenous status and diagnosis groups 
(Model II). Overall, the results for socio-
demographic covariates from Model II in 
Table 2 are qualitatively and quantitatively 
similar to the ones from Model I. In Table 3, we 
reported the LOS by Indigenous status and 
diagnosis groups and showed that there was 
no significant Indigenous status gap across 
diagnosis groups. 
Discussion
In the present study of a linked dataset 
describing an 11-year period, hospitalisations 
Table 1: Characteristics of LRTI-related hospital admissions, 2006-2016.
Characteristics All patients Non-indigenous Indigenous
Overall 11,629 100% 9,199 79.1% 2,430 20.9%
Age in years (mean, SD) *** 55.0 28.1 59.4 27.4 38.7 24.5
Age groups in years, n (%) ***
 0 < age < 3
 3 ≤ age < 20
 20 ≤ age < 40
 40 ≤ age < 60
 60 ≤ age < 85






































 Male 6,279 54.0% 5,023 54.6% 1,256 51.7%
 Female ** 5,350 46.0% 4,176 45.4% 1,174 48.3%
Diagnosis groups, n (%) ***
 Influenza 1,065 9.2% 850 9.2% 215 8.8%
 Pneumonia 7471 64.2% 6,031 65.6% 1440 59.3%
 Bronchitis 731 6.3% 472 5.1% 259 10.7%
 Other 2362 20.3% 1,846 20.1% 516 21.2%
Length of stay (LOS) in days (mean, SD) 10.9 23.8 10.7 19.1 11.4 36.5
ICU in hours, if >  0 (mean, SD) 178.1 246 171.5 222.3 192.9 292.3
IRSD SEIFA (mean, SD) *** 983.7 55.1 990.6 38.6 957.7 89.7
Mortality, n (%) *** 877 7.5% 793 8.6% 84 3.5%
Admission source, n (%) ***       
 Hospital’s ED 8,264 71.1% 6620 72.0% 1,644 67.7%
 Hospital’s outpatient department 726 6.2% 591 6.4% 135 5.6%
 Transferred from another hospital 1,098 9.4% 677 7.4% 421 17.3%
 Other 1,541 13.3% 1,311 14.3% 230 9.5%
Care type, n (%) ***       
 Acute 10,970 94.3% 8,611 93.6% 2,359 97.1%
 Palliative care 201 1.7% 186 2.0% 15 0.6%
 Rehabilitation care 155 1.3% 141 1.5% 14 0.6%
 Other 303 2.6% 261 2.8% 42 1.7%
Notes:
Differences in the means or proportions are tested between Indigenous and non-Indigenous samples (*** significant at 1%; ** significant at 5 %; * 
significant at 10%).







Figure 1: Monthly dynamics of LRTI-related hospital admissions.
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due to LRTIs were mostly for pneumonia 
(64.3%), influenza (9.1%) and bronchitis 
(6.2%). There was a general upward 
trend in LRTIs (influenza, pneumonia and 
bronchitis) during the 11-year study period. 
The population of the Townsville region 
increased by more than 21% during the 
sample period and this is a likely contributor 
to the increasing trend in hospital admissions. 
The burden of respiratory illnesses was 
disproportionately large for the Indigenous 
population, being the fourth most common 
cause for hospitalisation. This diagnosis 
was the seventh most common for the 
non-Indigenous population.5 The burden of 
LRTIs can also be exacerbated as they can 
aggravate chronic respiratory and medical 
conditions, such as asthma13 and heart 
failure,14 which are also more prevalent 
in the Indigenous population. LRTIs have 
major public health and costs implications 
as they are common infections, especially 
during colder months, and can be a direct 
or indirect cause of illness. Heath policies 
directed at early identification of LRTIs 
and raising awareness of the LRTIs within 
regional communities can reduce the 
current and future burden of disease on the 
Indigenous and non-Indigenous populations. 
Furthermore, as a larger proportion of 
Indigenous than non-Indigenous patients 
reside in rural and remote communities, 
they are more likely to require inter-
hospital transfer due to the limited health 
services available.15 Timely access to care 
is important to promptly identify and treat 
LRTI to avoiding the development of greater 
morbidity. 
We found admission rates (per 100,000 
people) for pneumonia, influenza and 
bronchitis to be higher among Indigenous 
patients than non-Indigenous patients. 
Notably, the H1N1 swine flu epidemic 
in 2009 disproportionally affected the 
Indigenous population in this study, as has 
been found elsewhere,16 not only in the 
area serviced by the Townsville hospital, but 
also the Top End of northern Australia.17,18 
During this epidemic, Indigenous patients 
experienced a hospitalisation rate that was 
eight to 12 times higher, respectively, to 
that experienced by the non-Indigenous 
population.17,18 This is comparable to other 
studies outside Australia that found higher 
rates of LTRIs among minority populations 
including Black adults in the US,19,20 Maori in 
New Zealand21 and Pakistanis in Scotland.22 
The 2012 influenza season, predominantly 
driven by the H3N2 strain,23 was particularly 
burdensome for the Indigenous population 
with the hospitalisation rate increasing by 
70% (17.5 admissions per 10,000 Indigenous 
residents) compared to the 2009 epidemic. 
Disproportionately high rates of pneumonia 
admissions for the Indigenous population 
with large increases in presentations 
occurring in the winter season24 across our 
observation period is also concerning, as 
pneumonia is a significant contributor to 
Indigenous respiratory-related deaths.25 
There has not been a consistent trend in the 
reduction of these differences over time. 
Thus, the higher prevalence of respiratory 
infections in the Indigenous population 
suggests the health gap is not closing. 
Significant gaps in socioeconomic 
characteristics between Indigenous and 
non-Indigenous populations also contribute 
to a higher prevalence of respiratory 
illnesses.26 In 2017, 39% of the disparity in 
health outcomes between Indigenous and 
non-Indigenous populations was linked to 
social determinants, including employment 
status, education outcomes and household 
 
Figure 2: Rates of admissions by diagnosis status and Indigenous status.
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income level.25 In this study, more Indigenous 
than non-Indigenous patients lived in 
areas that were more socioeconomically 
disadvantaged. The indigenous population is 
more likely to face housing problems, such as 
overcrowded dwellings with poor ventilation, 
which contribute to the increased risk of 
LRTIs among Indigenous people. Without 
addressing socioeconomic disadvantage, 
reducing poverty and improving living 
conditions, it would be difficult to change 
health behaviours and reduce the burden 
from respiratory infections, including LRTIs.
Smoking (including passive exposure) 
is another important contributor to the 
increased risk of LRTIs among Indigenous 
people. The prevalence of smoking among 
the Indigenous population is almost 
three times higher (38%) than among 
the non-Indigenous population (13%).27 
Active smoking increases the risks of 
hospital admissions due to pneumonia and 
influenza-associated infections;28,29 it is likely 
a contributing factor to the development 
of severe complications, and hence higher 
LOS, as a result of the higher burden of 
underlying chronic conditions and other 
non-communicable diseases Indigenous 
population experience. Previous studies have 
shown that public health messages about 
harms from smoking and social marketing 
anti-smoking campaigns can be effective 
and increase interest and participation from 
Indigenous community members in smoking 
cessation programmes if they involve local 
champions and are culturally and locally 
tailored.30,31 
The previous patterns of LRTI dynamics, 
particularly for pneumonia and influenza, 
can provide insights for Indigenous health 
experts and community leaders on the 
increasing burden of respiratory infections 
during epidemics. In the times of COVID-19, 
there have been growing concerns about 
the risks of COVID-19 spread in vulnerable 
populations, such as Indigenous people, who 
have a high prevalence of comorbidities and 
risk factors for LRTIs.32 In response to these 
heightened risks, the Australian Government 
provided additional financial and health 
resources to support remote communities 
and facilitate culturally safe access to 
COVID-19 testing and healthcare.33,34 
Furthermore, successful implementation of 
evidence-based and culturally translated 
COVID-19 prevention messages, prepared 
and delivered by Aboriginal Community 
Controlled Health Organisations, helped to 
Table 2: Determinants of the LOS (in days) from the negative binomial model.

























































































Total number of observations for all patients equals to 11,629. In all models, we include month and year fixed effects. Standard errors are clustered by patient. 
There is evidence of overdispersion tested by the χ2 test with p-value < 0.001. *** significant at 1 percent; ** significant at 5 percent;.
reduce the risks of COVID-19 community 
transmission.35 
In this study, the use of palliative and 
rehabilitation care was lower among 
Indigenous people than the non-Indigenous 
population. In addition to the observed 
skewed demographic profile observed for 
Indigenous people due to premature adult 
deaths, environmental and contextual issues, 
institutional barriers, awareness, perceptions 
and interpersonal client–clinician interactions 
are notable challenges in healthcare and 
palliative care use among the Indigenous 
population.36,37 However, the previous study 
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found that the uptake of these healthcare 
services can be improved through the well-
established Indigenous medical facilities and 
teams.38
Engagement and partnership with 
Indigenous communities, including 
representation of Aboriginal and Torres Strait 
Islander health workers and liaison officers 
within THHS teams, have been important 
aspects of “developing and providing 
culturally appropriate, outcomes-oriented 
healthcare to Aboriginal and Torres Strait 
Islander patients”.39 Thus, the number of 
Aboriginal and Torres Strait health workers 
in the THHS has improved from 154 (2.9% of 
THHS workforce) in 2017 to 208 in 2019 (3.8% 
of THHS workforce).40 The positive dynamic 
is encouraging and THHS has Indigenous 
Health Workers embedded in the maternity 
ward, children’s ward, renal units, cardiac 
units, mental health services, and community 
health, sexual health and rural facilities. The 
hospital also employs Indigenous Hospital 
Liaison Officers to help Aboriginal and 
Torres Strait Islander clients, their families 
and carers to access culturally appropriate 
healthcare and services. Furthermore, in 
line with the Engagement strategy, THHS 
developed a Reconciliation Action Plan 
that aims to build better relationships with 
Indigenous communities and consumers, 
while implementing culturally appropriate 
healthcare service delivery. These practices 
can particularly benefit the elderly 
and improve their use of palliative and 
rehabilitation care in a culturally safe and 
appropriate environment. Overall, these 
efforts focus on reducing health disparities 
between Indigenous and non-Indigenous 
people.
The main strength of this study is the use of 
a large hospital linked database with high 
reliability of disease classification coding 
(ICD10-AM) due to strict internal and external 
controls of this process. However, one of 
the limitations is that the data are from a 
single hospital in tropical northern Australia. 
Hence, it cannot be generalised to the entire 
population of Australia. The second limitation 
is that this study was not based on lab-
confirmed cases of LRTI but hospital coding. 
However, the use of ICD10-AM for diagnoses 
have been shown to show high specificity 
and sensitivity.41 Lastly, we described 
‘Indigenous’ as Aboriginal and Torres Strait 
Islander people. As stated in O’Grady et al.,42 
this descriptor encompasses a group of 
people with varying locations, socioeconomic 
status, cultures and belief systems that might 
influence their perception and treatment 
of respiratory disease. Despite the above-
mentioned limitations, the findings LRTI 
dynamics and determinants of LOS across 
Indigenous and non-Indigenous regional 
populations will be useful in providing 
decision makers with empirical evidence that 
is needed for effective planning and control 
strategies.
Conclusion
In this study, we examined the differences in 
the rates of lower respiratory tract infections 
amongst Indigenous and non-Indigenous 
Australian hospital inpatients. We highlighted 
the increased burden of LRTIs experienced 
by Indigenous populations in the far 
north of Australia with this information 
potentially being useful for enhancing 
community-level policy making. A preventive 
emphasis on improved vaccination rates for 
pneumonia pathogens including influenza 
and smoking cessation programs may be 
helpful in reducing the burden of diseases 
and public health risks. These efforts can 
be complemented by the improvements 
in engagement and partnership with 
Indigenous communities, particularly 
increasing the number of Indigenous health 
workers. Raising the awareness of the 
availability of healthcare and palliative care 
by providing culturally appropriate health 
resources and promoting yarning circles 
can help Indigenous communities increase 
healthcare uptake and the use of palliative 
care, thereby reducing the burden of 
respiratory diseases. 
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